...cts and scores endothelial dysfunction in cardiovascular disease through the different states of the disease.iMUC EndoPATTM diagnostic technology is based on the PAT® signal biomarker developed by Itamar Medical. It is a non-invasive, robust and totally non-operator-dependent technology and thus could fit well into clinical settings, providing an enhanced tool to improve disease management.iMUC ...